Cernilton herb for prostate enlargement treatment

Cernilton is made from the rye-grass pollen Secale cereale. In addition to saw palmetto and pygeum africanum, Cernilton is a popular herbal extract found in many over the counter herbal prostate formulas. It is used for the treatment of prostate enlargement symptoms.

Is Cernilton pill effective in the treatment of an enlarged prostate gland?
As of 2011, Cernilton studies have been limited and of short duration. It appears that it may offer mild improvements to men with an enlarged prostate gland.

Prostate Power Rx Supplement Facts
Saw palmetto extract
Stinging Nettle extract
Quercetin nutrient
Rosemary extract
Beta-Sitosterol supplement
Pygeum extract
Daidzein and Genistein (standardized to contain 40% isoflavones)
(treatment with the isoflavones daidzein and genistein, the estrogen-like compounds found in soy, block prostate growth in rats)

Cernilton for BPH therapy
A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia
Zhonghua Nan Ke Xue. 2008.
To compare the efficacy and safety of different doses of cernilton in preventing the clinical progression of benign prostatic hyperplasia (BPH). A total of 240 BPH patients with the International Prostate Symptom Score (IPSS) >7 were equally allocated to an experimental and a control group and treated with oral cernilton (Prostate), the former at the dose of 750 mg, the latter at 375 mg, both twice a day for 4 years. Changes, of IPSS, prostate volume, postvoid residual urine, maximum flow rate (Qmax), prostate specific antigen (PSA), the incidence of urine retention and the rate of surgery were compared between the two groups after the treatment. No toxic and side effects were observed. Long-term administration of cernilton at the dose of 750 mg may achieve faster and more obvious efficacy than at 375 mg in improving symptomatic BPH and preventing the clinical progression of BPH, with no side effects.

Prostatitis treatment
A pollen extract Cernilton in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
Eur Urol. 2009. Clinic for Urology, Paediatric Urology and Andrology, Justus-Liebig-University of Giessen, Giessen, Germany.
National Institutes of Health (NIH) category III prostatitis / chronic pelvic pain syndrome (CP/CPPS) is a prevalent condition for which no standardised treatment exists. To assess the safety and efficacy of a standardised pollen extract in men with inflammatory CP/CPPS. We conducted a multicentre, prospective, randomised, double-blind, placebo-controlled phase 3 study comparing the pollen extract (Cernilton) to placebo in men with CP/CPPS (NIH IIIA) attending urologic centres. Participants were randomised to receive oral capsules of the pollen extract (two capsules q8h) or placebo for 12 wk. MEASUREMENTS: The primary endpoint of the study was symptomatic improvement in the pain domain of the NIH Chronic Prostatitis Symptom Index (NIH-CPSI). Participants were evaluated using the NIH-CPSI individual domains and total score, the number of leukocytes in post-prostatic massage urine (VB3), the International Prostate Symptom Score (IPSS), and the sexuality domain of a life satisfaction questionnaire at baseline and after 6 and 12 wk. In the intention-to-treat analysis, 139 men were randomly allocated to the pollen extract (n=70) or placebo (n=69). The individual domains pain and quality of life as well as the total NIH-CPSI score (p=0.0126) were significantly improved after 12 wk of treatment with pollen extract compared to placebo. Response, defined as a decrease of the NIH-CPSI total score by at least 25% or at least 6 points, was seen in the pollen extract versus placebo group in 70% and 50%, respectively. Adverse events were minor in all patients studied. Compared to placebo, the pollen extract significantly improved total symptoms, pain, and QoL in patients with inflammatory CP/CPPS without severe side-effects.

Cernilton side effects, safety
Cernilton appears to be well tolerated with few side effects.

Q. I am more than slightly confused why this website solicits via specific keywords cernilton, and appears to tout the benefits of cernilton (true rye flower pollen), while the product contains none of the same? Is there some logical (read medical or scientific) reason for the omission.
   A. Our website has research on different supplements, and on some pages we have products that refer to the actual product we discuss, and on other pages we discuss the research on a product but we don't carry it.